Mahana Therapeutics
Location: United States, California, San Francisco
Employees: 11-50
Total raised: $61M
Founded date: 2018
Investors 4
| Date | Name | Website |
| - | Outsized V... | outsized.v... |
| - | BXR Partne... | bxrgroup.c... |
| - | Lux Capita... | luxcapital... |
| 08.12.2020 | Luminous V... | luminous.v... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.08.2021 | Series B | $61M | - |
Mentions in press and media 6
| Date | Title | Description |
| 29.07.2022 | AmerisourceBergen Launches EHR-Integrated Digital Therapeutics Platform | What You Should Know: This week, AmerisourceBergen announced plans to launch DTx Connect, a fully integrated ordering, dispensing and fulfillment platform that aims to facilitate patient access to physician-ordered digital therapeutics and ... |
| 17.03.2022 | World IBS Day - April 19th: The IBS Experience for IBS Sufferers | April 19th is World IBS Day. Help raise awareness this April 19th by using #WorldIBSDay on social media. TORONTO (PRWEB) March 17, 2022 Irritable Bowel Syndrome (IBS) is often stigmatized and misunderstood with symptoms significantly impact... |
| 07.12.2021 | FDA clears digital therapeutic for abdominal pain from IBS | Irritable bowel syndrome, one of the most commonly diagnosed GI conditions, is estimated to affect roughly 10% of adults in the U.S. The condition, characterized by abdominal pain, bloating, and diarrhea or constipation, can have different ... |
| 11.08.2021 | Mahana Therapeutics Raises $61M in Series B Financing | Mahana Therapeutics, a San Francisco, CA-based developer of prescription digital therapeutics designed to empower patients with chronic health conditions, raised $61m in Series B financing. The round was led by JAZZ Venture Partners and Gur... |
| 23.12.2020 | 8 Digital Health Predictions For 2021 | getty |
| - | FDA clears digital therapeutic for abdominal pain from IBS | Irritable bowel syndrome, one of the most commonly diagnosed GI conditions, is estimated to affect roughly 10% of adults in the U.S. The condition, characterized by abdominal pain, bloating, and diarrhea or constipation, can have different ... |